Mostrar el registro sencillo del documento

Precáncer anogenital: nuevos horizontes para el ginecólogo

dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.contributor.advisorAmaya Guío, Jairo
dc.contributor.advisorDíaz Cruz, Luz Amparo
dc.contributor.authorPeralta Jiménez, Jonathan Alexander
dc.contributor.authorLópez Ríos, Jesús Antonio
dc.contributor.authorArcos Arcos, Hector Fernando
dc.date.accessioned2021-01-25T14:26:29Z
dc.date.available2021-01-25T14:26:29Z
dc.date.issued2020-10-25
dc.identifier.citationPeralta, J; López, J. & Arcos, H. (2020). Precáncer anogenital: nuevos horizontes para el ginecólogo [Tesis de especialidad, Universidad Nacional de Colombia]. Repositorio Institucional.
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/78896
dc.description.abstractEl presente libro es fruto de un arduo trabajo, que pretende condensar de una manera práctica y ordenada, al virus del papiloma humano, su biología misma, y su injerencia en el desarrollo de distintas lesiones premalignas, no solo a nivel del cérvix, sino también, de la vulva, ano, y vagina. La información recolectada en este escrito, se basa en la mejor, y más reciente evidencia disponible. Esto con el apoyo incondicional de los mejores profesores, cada uno de ellos, quienes colaboraron desde su experiencia a la formación de cada uno de estos capítulos. Cada capítulo pretende dejar unas enseñanzas básicas, en cada uno de los campos desarrollados. Cada capítulo utiliza herramientas dinámicas como imágenes, gráficas, diagramas de flujo que pretenden dinamizar el conocimiento. Este libro esta dirigido al estudio complementario y enseñanza de estudiantes de pregrado de medicina, médicos generales, médicos en formación en obstetricia y ginecología, especialistas en el área de la ginecología y obstetricia, y cualquier otro integrante del personal de salud que desee ahondar en esta área.
dc.description.abstractThis book is the result of hard work, which aims to condense, in a practical and orderly way, the human papilloma virus, its biology, and its interference in the development of different premalignant lesions, not only at the level of the cervix, but also, of the vulva, anus, and vagina. The information collected in this writing is based on the best and most recent evidence available. This with the unconditional support of the best teachers, each of them, who collaborated from their experience to the formation of each of these chapters. Each chapter tries to leave some basic learnings, in each one of the developed fields. Each chapter uses dynamic tools such as images, graphs, diagrams that aim to dynamize the knowledge. This book is aimed at the complementary study and teaching of undergraduate medical students, general practitioners, doctors in training in obstetrics and gynecology, specialists in the area of ​​gynecology and obstetrics, and any other member of the health personnel who wishes to delve into this zone.
dc.format.extent246
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rightsDerechos reservados - Universidad Nacional de Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610 - Medicina y salud
dc.subject.ddc618 - Ginecología, obstetricia, pediatría, geriatría
dc.titlePrecáncer anogenital: nuevos horizontes para el ginecólogo
dc.typeOtro
dc.rights.spaAcceso abierto
dc.type.driverinfo:eu-repo/semantics/other
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dc.publisher.programBogotá - Medicina - Especialidad en Obstetricia y Ginecología
dc.description.degreelevelEspecialidades Médicas
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.referencesMcBride AA, Münger K. Expert views on HPV infection. Viruses [Internet]. 2018 Feb 24 [cited 2020 Nov 28];10(2). Available from: https://pubmed.ncbi.nlm.nih.gov/29495253/
dc.relation.referencesMammas I. Clinical Virology research and medical education in Greece: An interview with Demetrios A. Spandidos, Professor of Clinical Virology at the University of Crete in Greece. Exp Ther Med [Internet]. 2019 Aug 28 [cited 2020 Nov 28];18(4):3221. Available from: /pmc/articles/PMC6766560/?report=abstrac
dc.relation.referencesDe Stavola B. Statistical facts about cancers on which doctor Rigoni‐stern based his contribution to the Surgeons’ Subgroup of the IV Congress of the Italian Scientists on 23 September 1842. Stat Med [Internet]. 1987 [cited 2020 Nov 28];6(8):881–4. Available from: https://pubmed.ncbi.nlm.nih.gov/3326103/
dc.relation.referencesValerio M. Una historia de liebres, monjas y prepucios | elmundo.es salud [Internet]. 2007 [cited 2020 Nov 28]. Available from: https://www.elmundo.es/elmundosalud/2007/10/09/oncologia/1191921844.htm
dc.relation.referencesBroso PR, Buffetti G. George Nicholas Papanicolaou. Minerva Ginecol. 1993;45(10):511–6.
dc.relation.referencesGissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A [Internet]. 1983 [cited 2020 Nov 28];80(2 I):560–3. Available from: https://pubmed.ncbi.nlm.nih.gov/6300854/
dc.relation.referencesFrazer I. Vaccines for papillomavirus infection. In: Virus Research. Elsevier; 2002. p. 271–4.
dc.relation.referencesVorsters A, Bosch FX, Bosch FX, Bonanni P, Franco EL, Baay M, et al. Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report. BMC Proc [Internet]. 2020 Jun 22 [cited 2020 Nov 28];14(Suppl 9):8. Available from: /pmc/articles/PMC7307134/?report=abstract
dc.relation.referencesRío-Ospina L Del, León SCS De, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, et al. The prevalence of high-risk HPV types and factors determining infection in female colombian adolescents. PLoS One [Internet]. 2016 Nov 1 [cited 2020 Nov 28];11(11). Available from: /pmc/articles/PMC5112891/?report=abstract
dc.relation.referencesArbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Heal [Internet]. 2020 Feb 1 [cited 2020 Nov 28];8(2):e191–203. Available from: https://pubmed.ncbi.nlm.nih.gov/31812369/
dc.relation.referencesColombia SG de SS en S de. Inicio | Cuenta de Alto Costo [Internet]. Ministerio de Salud. 2019 [cited 2020 Nov 28]. Available from: https://cuentadealtocosto.org/site/
dc.relation.referencesZehender G, Frati ER, Martinelli M, Bianchi S, Amendola A, Ebranati E, et al. Dating the origin and dispersal of Human Papillomavirus type 16 on the basis of ancestral human migrations. Infect Genet Evol. 2016 Apr 1;39:258–64.
dc.relation.referencesBruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, De Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis [Internet]. 2010 Dec 15 [cited 2020 Nov 28];202(12):1789–99. Available from: https://pubmed.ncbi.nlm.nih.gov/21067372/
dc.relation.referencesLópez N, Viayna E, San-Martin M, Perulero N. Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura. Vacunas. 2017 Jul 1;18(2):36–42.
dc.relation.referencesMortaki D, Gkegkes I, Psomiadou V, Blontzos N, Prodromidou A, Lefkopoulos F, et al. Vaginal microbiota and human papillomavirus: A systematic review [Internet]. Vol. 21, Journal of the Turkish German Gynecology Association. Galenos; 2020 [cited 2020 Nov 28]. p. 193–200. Available from: /pmc/articles/PMC7495129/?report=abstract
dc.relation.referencesChaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol [Internet]. 2011 Nov 10 [cited 2020 Nov 28];29(32):4294–301. Available from: /pmc/articles/PMC3221528/?report=abstract
dc.relation.referencesGooi Z, Chan JYK, Fakhry C. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer [Internet]. Vol. 126, Laryngoscope. John Wiley and Sons Inc.; 2016 [cited 2020 Nov 28]. p. 894–900. Available from: https://pubmed.ncbi.nlm.nih.gov/26845348/
dc.relation.referencesQuintero K, Giraldo GA, Uribe ML, Baena A, Lopez C, Alvarez E, et al. Genótipos de vírus de papiloma humano em carcinoma de células escamosas de cabeça e pescoço na Colômbia. Braz J Otorhinolaryngol [Internet]. 2013 [cited 2020 Nov 28];79(3):375–81. Available from: https://pubmed.ncbi.nlm.nih.gov/23743755/
dc.relation.referencesIslami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol [Internet]. 2017 Jun 1 [cited 2020 Nov 28];46(3):924–38. Available from: https://academic.oup.com/ije/article/46/3/924/2447873
dc.relation.referencesPosso H, León-Maldonado L, Allen-Leigh B, Salmerón J, Quiterio M, Giuliano AR, et al. Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies. Salud Publica Mex. 2018 Nov 1;60(6):645–52.
dc.relation.referencesStier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: A systematic review [Internet]. Vol. 213, American Journal of Obstetrics and Gynecology. Mosby Inc.; 2015 [cited 2020 Nov 28]. p. 278–309. Available from: /pmc/articles/PMC4556545/?report=abstract
dc.relation.referencesSehnal B, Podlešák T, Kmoníčková E, Nipčová M, Driák D, Sláma J, et al. Anogenital HPV infection as the potential risk factor for oropharyngeal carcinoma. Klin Onkol [Internet]. 2018 [cited 2020 Nov 28];31(2):103–9. Available from: https://pubmed.ncbi.nlm.nih.gov/29708352/
dc.relation.referencesGarland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, et al. Human Papillomavirus Genotypes from Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. Obstet Gynecol [Internet]. 2018 [cited 2020 Nov 28];132(2):261–70. Available from: https://pubmed.ncbi.nlm.nih.gov/29995724/
dc.relation.referencesSatmary W, Holschneider CH, Brunette LL, Natarajan S. Vulvar intraepithelial neoplasia: Risk factors for recurrence. Gynecol Oncol [Internet]. 2018 Jan 1 [cited 2020 Nov 28];148(1):126–31. Available from: https://pubmed.ncbi.nlm.nih.gov/29126556/
dc.relation.referencesSuehiro TT, Damke GMZF, Damke E, De Azevedo Ramos PLR, De Andrade Pereira Silva M, Pelloso SM, et al. Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil. Infect Agent Cancer [Internet]. 2020 May 11 [cited 2020 Nov 28];15(1). Available from: /pmc/articles/PMC7216672/?report=abstract
dc.relation.referencesKahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol [Internet]. 2007 Jul [cited 2020 Nov 28];110(1):87–95. Available from: https://pubmed.ncbi.nlm.nih.gov/17601901/
dc.relation.referencesHuang X, Chen C, Zhu F, Zhang Y, Feng Q, Li J, et al. Association between Dietary Vitamin A and HPV Infection in American Women: Data from NHANES 2003-2016. Biomed Res Int. 2020;2020.
dc.relation.referencesHe AJ, Chen C, Jia M, Fan RQ. Dietary calcium intake and HPV infection status among American women: A secondary analysis from national health and nutrition examination survey (NHANES) data set of 2003 - 2016. Med Sci Monit [Internet]. 2020 May 7 [cited 2020 Nov 28];26:e921571-1. Available from: /pmc/articles/PMC7233009/?report=abstract
dc.relation.referencesTaylor S, Bunge E, Bakker M, Castellsagué X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: A systematic review of the literature. BMC Infect Dis [Internet]. 2016 Jun 14 [cited 2020 Nov 28];16(1). Available from: https://pubmed.ncbi.nlm.nih.gov/27301867/
dc.relation.referencesGrillo-Ardila CF, Martínez-Velásquez MY, Morales-López B. Virus del papiloma humano: aspectos moleculares y cáncer de cérvix. Rev Colomb Obstet Ginecol. 2008;59(4):310–5.
dc.relation.referencesConsuegra-Mayor CP, Molina-Campo D, Egea-Bermejo E, Garavito de Egea G. El virus del papiloma humano (HPV), agente viral importante precusor de la mayoría de las displasias o cáncer cervical. Salud Uninorte. 2004;2004(19):3–13.
dc.relation.referencesSerrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47(2018):14–26.
dc.relation.referencesHernández- Márquez CI, Salinas-Urbina AA, Cruz-Valdez A, Hernández-Girón C. Conocimientos sobre virus del papiloma humano (VPH) y aceptación de auto-toma vaginal en mujeres mexicanas. Rev Salud Publica. 2014;16(5):697–708.
dc.relation.referencesFouéré S, Biver-Dalle C, Prétet J-L, Mougin C, Aubin F. Lesiones cutáneas y mucosas asociadas al virus del papiloma humano. EMC - Dermatología. 2016;50(1):1–12.
dc.relation.referencesAraldi RP, Sant’Ana TA, Módolo DG, de Melo TC, Spadacci-Morena DD, de Cassia Stocco R, et al. The human papillomavirus (HPV)-related cancer biology: An overview. Biomed Pharmacother. 2018;106(June):1537–56
dc.relation.referencesDoorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30(SUPPL.5).
dc.relation.referencesLjubojevic S, Skerlev M. HPV-associated diseases. Clin Dermatol. 2014;32(2):227–34.
dc.relation.referencesGaitán-Duarte H. Las infecciones de transmisión sexual: un problema de salud pública que Colombia debe enfrentar. Rev Colomb Obstet Ginecol. 2017;68(3):164.
dc.relation.referencesCohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82.
dc.relation.referencesCohen PA, Anderson L, Eva L, Scurry J. Clinical and molecular classification of vulvar squamous pre-cancers. Int J Gynecol Cancer. 2019;29(4):821–8.
dc.relation.referencesDay PM, Weisberg AS, Thompson CD, Hughes MM, Pang YY, Lowy DR, et al. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection. J Virol. 2019;93(15):1–18.
dc.relation.referencesAksoy P, Gottschalk EY, Meneses PI. HPV entry into cells. Mutat Res - Rev Mutat Res. 2017;772:13–22.
dc.relation.referencesVonsky M, Shabaeva M, Runov A, Lebedeva N, Chowdhury S, Palefsky JM, et al. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy. Biochem. 2019;84(7):782–99.
dc.relation.referencesPańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis. Mol Diagnosis Ther. 2018;22(4):421–30.
dc.relation.referencesZięba S, Chechlińska M, Kowalik A, Kowalewska M. Genes, pathways and vulvar carcinoma - New insights from next-generation sequencing studies. Gynecol Oncol. 2020;158(2):498–506.
dc.relation.referencesDe Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450–61
dc.relation.referencesDe Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450–61. 18. Huang HS, Lambert PF. Use of an in vivo animal model for assessing the role of integrin α6Β4 and Syndecan-1 in early steps in papillomavirus infection. Virology. 2012;433(2):395–400.
dc.relation.referencesGrowth E, Receptor F. Epidermal Growth Factor Receptor and Abl2 Kinase Regulate. 2020;94(11):1–15.
dc.relation.referencesRoberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013;45(9):970–6.
dc.relation.referencesGupta S, Kumar P, Das BC. HPV: Molecular pathways and targets. Curr Probl Cancer. 2018;42(2):161–74.
dc.relation.referencesGraham S V. The human papillomavirus replication cycle, and its links to cancer progression: A comprehensive review. Clin Sci. 2017;131(17):2201–21.
dc.relation.referencesSo KA, Lee IH, Lee KH, Hong SR, Kim YJ, Seo HH, et al. Human papillomavirus genotype-specific risk in cervical carcinogenesis. J Gynecol Oncol. 2019;30(4):1–9.
dc.relation.referencesHoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends Microbiol. 2018;26(2):158–68.
dc.relation.referencesDasgupta S, Ewing-Graham PC, Swagemakers SMA, van der Spek PJ, van Doorn HC, Noordhoek Hegt V, et al. Precursor lesions of vulvar squamous cell carcinoma – histology and biomarkers: A systematic review. Vol. 147, Critical Reviews in Oncology/Hematology. Elsevier Ireland Ltd; 2020
dc.relation.referencesLópez-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS. Oncogenes and tumor angiogenesis: The HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene. 2000;19(40):4611–20.
dc.relation.referencesReutter JC. High-Yield Vulvar Histopathology for the Clinician. Obstet Gynecol Clin North Am. 2017;44(3):329–38
dc.relation.referencesBigby SM, Eva LJ, Fong KL, Jones RW. The natural history of vulvar intraepithelial neoplasia, differentiated type: Evidence for progression and diagnostic challenges. Int J Gynecol Pathol. 2016;35(6):574–84.
dc.relation.referencesvon Knebel Doeberitz M, Wentzensen N. The cell: Basic structure and Function. Compr Cytopathol. 2008;3–22.
dc.relation.referencesConesa-Zamora P. Immune responses against virus and tumor in cervical carcinogenesis: Treatment strategies for avoiding the HPV-induced immune escape. Gynecol Oncol. 2013;131(2):480–8.
dc.relation.referencesDiane M Harper HP study group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.
dc.relation.referencesvon Knebel Doeberitz M, Vinokurova S. Host Factors in HPV-related Carcinogenesis: Cellular Mechanisms Controlling HPV Infections. Arch Med Res. 2009;40(6):435–42.
dc.relation.referencesCarcopino X. Citología cervical y conducta práctica en caso de frotis anormal. EMC - Ginecol. 2019;55(1):1–11.
dc.relation.referencesWoodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: Unresolved issues. Nat Rev Cancer. 2007;7(1):11–22.
dc.relation.referencesJones SEF, Hibbitts S, Hurt CN, Bryant D, Fiander AN, Powell N, et al. Human papillomavirus DNA methylation predicts response to treatment using cidofovir and imiquimod in vulval intraepithelial neoplasia 3. Clin Cancer Res. 2017;23(18):5460–8.
dc.relation.referencesEstêvão D, Costa NR, Gil da Costa RM, Medeiros R. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Biochim Biophys Acta - Gene Regul Mech. 2019;1862(2):153–62.
dc.relation.referencesFerlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019 Apr 15;144(8):1941–53
dc.relation.referencesBosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah K V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 Apr 1;55(4):244–65.
dc.relation.referencesDe Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer. 2009 Apr 1;124(7):1626–36.
dc.relation.referencesIARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France; 1995.
dc.relation.referencesKessler TA. Cervical Cancer: Prevention and Early Detection. Semin Oncol Nurs. 2017 May;33(2):172–83.
dc.relation.referencesParikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003 Jul 10;105(5):687–91.
dc.relation.referencesOMS-OPS. Control integral del cáncer cervicouterino Guía de prácticas esenciales [Internet]. 2016 [cited 2020 Aug 11]. p. 420. Available from: https://iris.paho.org/bitstream/handle/10665.2/28512/9789275318799_spa.pdf?ua=1
dc.relation.referencesMurfin J, Irvine F, Meechan‐Rogers R, Swift A. Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review. J Clin Nurs. 2020 Feb 10;29(3–4):393–415.
dc.relation.referencesWorld Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations. Vaccine. 2017 Oct;35(43):5753–5.
dc.relation.referencesPandhi D, Sonthalia S. Human papilloma virus vaccines: Current scenario. Indian J Sex Transm Dis AIDS. 2011 Jul;32(2):75.
dc.relation.referencesBergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, et al. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database Syst Rev. 2019 Nov 22;2019(11).
dc.relation.referencesWHO. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec No 43. 2014;465–492.
dc.relation.referencesBergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, et al. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database Syst Rev. 2019;2019(11)
dc.relation.referencesPATH. Global HPV Vaccine Introduction Overview [Internet]. 2020 [cited 2020 Aug 12]. Available from: https://www.path.org/resources/global-hpv-vaccine-introduction-overview/
dc.relation.referencesKarafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccines Immunother. 2019 Aug 3;15(7–8):1615–27.
dc.relation.referencesGallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018 Aug;36(32):4761–7.
dc.relation.referencesVorsters A, Bosch FX, Bosch FX, Bonanni P, Franco EL, Baay M, et al. Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report. BMC Proc [Internet]. 2020;14(Suppl 9):1–13. Available from: http://dx.doi.org/10.1186/s12919-020-00192-2
dc.relation.referencesLowy DR, Herrero R, Hildesheim A. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. Lancet Oncol. 2015 May;16(5):e226–33.
dc.relation.referencesRees CP, Brhlikova P, Pollock AM. Will HPV vaccination prevent cervical cancer? J R Soc Med [Internet]. 2020;113(2):64–78. Available from: https://doi.org/10.1177/0141076819899308
dc.relation.referencesDrolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily M-C, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019 Aug;394(10197):497–509.
dc.relation.referencesArbyn M, Xu L, Simoens C, Martin-Hirsch PPL. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Vol. 2018, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2018.
dc.relation.referencesLukács A, Máté Z, Farkas N, Mikó A, Tenk J, Hegyi P, et al. The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis. BMC Public Health. 2020 Dec 28;20(1):691.
dc.relation.referencesHarder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: A systematic review. BMC Med. 2018 Jul 18;16(1).
dc.relation.referencesVorsters A, Arbyn M, Baay M, Bosch X, de Sanjosé S, Hanley S, et al. Overcoming barriers in HPV vaccination and screening programs. In: Papillomavirus Research. Elsevier B.V.; 2017. p. 45–53.
dc.relation.referencesChelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. Vol. 66, Journal of Infection. J Infect; 2013. p. 207–17.
dc.relation.referencesPontén J, Adami H ‐O, Bergström R, Dillner J, Friberg L ‐G, Gustafsson L, et al. Strategies for global control of cervical cancer. Int J Cancer. 1995;60(1):1–26.
dc.relation.referencesMcCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008 May;9(5):425–34.
dc.relation.referencesHerbert A. Relation between the incidence of invasive cervical cancer and the screening interval: Is a five year interval too long? J Med Screen. 1996;3(3):140–5.
dc.relation.referencesSankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV Screening for Cervical Cancer in Rural India. N Engl J Med. 2009 Apr 2;360(14):1385–94.
dc.relation.referencesJansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Vol. 127, European Journal of Cancer. Elsevier Ltd; 2020. p. 207–23.
dc.relation.referencesKasinpila C, Promthet S, Vatanasapt P, Sasieni P, Maxwell Parkin D. Evaluation of the nationwide cervical screening programme in thailand: A case-control study. J Med Screen. 2011 Sep;18(3):147–53.
dc.relation.referencesCastillo M, Astudillo A, Clavero O, Velasco J, Ibáñez R, de Sanjosé S. Evaluation of mortality after the analysis of the screening history in women diagnosed with infiltrating cervical cancer. Aten Primaria. 2018 Mar 1;50(3):151–8.
dc.relation.referencesMájek O, Dušková J, Dvořák V, Beková A, Klimeš D, Blaha M, et al. Performance indicators in a newly established organized cervical screening programme: Registry-based analysis in the Czech Republic. Eur J Cancer Prev. 2017;26(3):232–9.
dc.relation.referencesDe Stavola B. Statistical facts about cancers on which doctor Rigoni-stern based his contribution to the Surgeons’ Subgroup of the IV Congress of the Italian Scientists on 23 September 1842. Stat Med. 1987 Dec 1;6(8):881–4.
dc.relation.referencesNayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytol. 2015 Jun 15;59(2):121–32.
dc.relation.referencesTewari Lt Col R. LCR, Chaudhary Col A. CA. Atypical squamous cells of undetermined significance: A follow up study. Med J Armed Forces India. 2010;66(3):225–7.
dc.relation.referencesDe Oliveira GG, De Oliveira JMDSC, Eleutério RMN, Barbosa RDCC, De Almeida PRC, Eleutério J. Atypical squamous cells: Cytopathological findings and correlation with HPV genotype and histopathology. Acta Cytol. 2018 Dec 1;62(5–6):386–92.
dc.relation.referencesNdifon CO, Al-Eyd G. Atypical squamous cells of undetermined significance (ASCUS). Vol. 52, International Journal of Gynecology and Obstetrics. John Wiley and Sons Ltd; 1996. p. 215–6.
dc.relation.referencesFujiwara H, Suzuki M, Morisawa H, Sayama M, Kimura K. The impact of triage for atypical squamous cells of undetermined significance with human papillomavirus testing in cervical cancer screening in Japan. Asian Pacific J Cancer Prev. 2019 Jan 1;20(1):81–5.
dc.relation.referencesFujiwara H, Suzuki M, Morisawa H, Sayama M, Kimura K. The impact of triage for atypical squamous cells of undetermined significance with human papillomavirus testing in cervical cancer screening in Japan. Asian Pacific J Cancer Prev. 2019 Jan 1;20(1):81–5.
dc.relation.referencesGoyal A, Street J, Alperstein SA, Siddiqui MT. HPV test result monitoring of different Bethesda categories in gynaecologic cytology: A valuable quality assurance measure. Diagn Cytopathol. 2018 Nov 1;46(11):914–8
dc.relation.referencesLandy R, Castanon A, Hamilton W, Lim AWW, Dudding N, Hollingworth A, et al. Evaluating cytology for the detection of invasive cervical cancer. Cytopathology. 2016 Jun 1;27(3):201–9.
dc.relation.referencesLandy R, Sasieni PD, Mathews C, Wiggins CL, Robertson M, McDonald YJ, et al. Impact of screening on cervical cancer incidence: A population-based case–control study in the United States. Int J Cancer. 2020 Aug 1;147(3):887–96.
dc.relation.referencesDalla Palma P, Moresco L, Giorgi Rossi P. Health technology assessment of computer-assisted pap test screening in italy. Acta Cytol. 2013;57(4):349–58.
dc.relation.referencesDavey S, Davey A. Effect of practice management among physicians of developing countries with special reference to Indian scenario by Mixed Method Technique. J Fam Med Prim Care. 2015;4(2):208.
dc.relation.referencesCheung ANY, Szeto EF, Leung BSY, Khoo US, Ng AWY. Liquid-Based Cytology and Conventional Cervical Smears: A Comparison Study in an Asian Screening Population. Cancer. 2003 Dec 25;99(6):331–5.
dc.relation.referencesLatsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, et al. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg. Diagn Cytopathol. 2017 May 1;45(5):384–90
dc.relation.referencesPan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, et al. Liquid-based cytology and human papillomavirus testing: A pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Gynecol Oncol. 2014 May 1;133(2):172–9.
dc.relation.referencesKoliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PPL, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Vol. 2017, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2017.
dc.relation.referencesTatiana Ramírez-Pineda A, Isabel González M, Melisa Castañeda-Vanegas K, Cecilia Agudelo-Fernández M, López-Urán C, Inés Sánchez-Vásquez G, et al. Filogenia y oncogénesis del virus del papiloma humano: una aproximación translacional al descubrimiento de biomarcadores para la detección de lesiones precancerosas de cérvix Ciencias Biomédicas Artículo de posesión.
dc.relation.referencesOMS. Integrating hpv testing in cervical cancer screening programs a manual for program managers cervical cancer prevention in latin america and the caribbean. 2016.
dc.relation.referencesOgembo RK, Gona PN, Seymour AJ, Park HSM, Bain PA, Maranda L, et al. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: A systematic review and meta-analysis. Vol. 10, PLoS ONE. Public Library of Science; 2015.
dc.relation.referencesWright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015 Feb 1;136(2):189–97.
dc.relation.referencesMelnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Soulsby MA. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force. 2018.
dc.relation.referencesKi EY, Lee YK, Lee A, Park JS. Comparison of the PANArray HPV genotyping chip test with the cobas 4800 HPV and hybrid capture 2 tests for detection of HPV in ASCUS women. Yonsei Med J. 2018 Jul 1;59(5):662–8.
dc.relation.referencesGe Y, Christensen P, Luna E, Armylagos D, Schwartz MR, Mody DR. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer. Cancer Cytopathol. 2017 Aug 1;125(8):652–7.
dc.relation.referencesSegondy M, Kelly H, Magooa MP, Djigma F, Ngou J, Gilham C, et al. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study. Br J Cancer. 2016 Aug 9;115(4):425–30.
dc.relation.referencesWright TC, Stoler MH, Parvu V, Yanson K, Cooper C, Andrews J. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology. Gynecol Oncol. 2019 Aug 1;154(2):360–7.
dc.relation.referencesLuo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF. Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status. Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232–8.
dc.relation.referencesArbyn M, Xu L, Verdoodt F, Cuzick J, Szarewski A, Belinson JL, et al. Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: A systematic review and meta-analysis. Vol. 166, Annals of Internal Medicine. American College of Physicians; 2017. p. 118–27.
dc.relation.referencesOgilvie GS, Van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, et al. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: The HPV FOCAL randomized clinical trial. JAMA - J Am Med Assoc. 2018 Jul 3;320(1):43–52.
dc.relation.referencesSchiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, et al. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening. J Natl Cancer Inst. 2018 May 1;110(5):501–8.
dc.relation.referencesMaged AM, Saad H, Salah E, Meshaal H, AbdElbar M, Omran E, et al. Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening. Int J Gynecol Obstet. 2018 Jun 1;141(3):332–6.
dc.relation.referencesAsciutto KC, Henningsson AJ, Borgfeldt H, Darlin L, Borgfeldt C. Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the cobas 4800 HPV test. Anticancer Res. 2017 Aug 1;37(8):4183–7.
dc.relation.referencesEl-Zein M, Richardson L, Franco EL. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. Vol. 76, Journal of Clinical Virology. Elsevier B.V.; 2016. p. S62–8.
dc.relation.referencesCanfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, et al. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. PLoS Med. 2017 Sep 1;14(9).
dc.relation.referencesLei J, Ploner A, Lehtinen M, Sparén P, Dillner J, Elfström KM. Impact of HPV vaccination on cervical screening performance: a population-based cohort study. Br J Cancer. 2020 Jul 7;123(1):155–60.
dc.relation.referencesWentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, et al. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. J Natl Cancer Inst. 2015 Dec 1;107(12):djv257.
dc.relation.referencesClarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, et al. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women. JAMA Oncol. 2019 Feb 1;5(2):181–6.
dc.relation.referencesWentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, et al. Clinical Evaluation of Human Papillomavirus Screening with p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. JAMA Intern Med. 2019 Jul 1;179(7):881–8.
dc.relation.referencesStoler MH, Baker E, Boyle S, Aslam S, Ridder R, Huh WK, et al. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology—Retrospective insights from ATHENA. Int J Cancer. 2020 May 1;146(9):2599–607.
dc.relation.referencesGamboa Ó, González M, Bonilla J, Luna J, Murillo R, Cendales R, et al. Visual techniques for cervical cancer screening in Colombia. Biomedica. 2019;39(1):65–74.
dc.relation.referencesRaifu AO, El-Zein M, Sangwa-Lugoma G, Ramanakumar A, Walter SD, Franco EL, et al. Determinants of cervical cancer screening accuracy for visual inspection with acetic acid (VIA) and lugol’s iodine (VILI) performed by nurse and physician. PLoS One. 2017 Jan 1;12(1).
dc.relation.referencesHuchko MJ, Sneden J, Zakaras JM, Smith-McCune K, Sawaya G, Maloba M, et al. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to visual inspection with Lugol’s iodine for cervical cancer screening in HIV infected women. PLoS One. 2015 Apr 7;10(4).
dc.relation.referencesBenski AC, Viviano M, Jinoro J, Alec M, Catarino R, Herniainasolo J, et al. HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women. PLoS One. 2019 Aug 1;14(8).
dc.relation.referencesThay S, Goldstein A, Goldstein LS, Govind V, Lim K, Seang C. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: A comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy. BMJ Open. 2019 Feb 1;9(2):26887.
dc.relation.referencesArbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: Updated meta-analyses. BMJ. 2018 Dec 5;363:4823.
dc.relation.referencesSong F, Du H, Wang C, Huang X, Wu R. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples. Meyers C, editor. PLoS One. 2020 Jun 11;15(6):e0234518.
dc.relation.referencesJede F, Brandt T, Gedefaw M, Wubneh SB, Abebe T, Teka B, et al. Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia. Papillomavirus Res. 2020 Jun 1;9:100198.
dc.relation.referencesNaz MSG, Kariman N, Ebadi A, Ozgoli G, Ghasemi V, Fakari FR. Educational interventions for cervical cancer screening behavior of women: A systematic review. Vol. 19, Asian Pacific Journal of Cancer Prevention. Asian Pacific Organization for Cancer Prevention; 2018. p. 875–84.
dc.relation.referencesMustafa RA, Santesso N, Khatib R, Mustafa AA, Wiercioch W, Kehar R, et al. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. Vol. 132., International Journal of Gynecology and Obstetrics. Elsevier Ireland Ltd; 2016. p. 259–65.
dc.relation.referencesMacLean JS. The Life of Hans Hinselmann. Obstet Gynecol Surv. 1979 Nov;34(11):788–9.
dc.relation.referencesPowell JL. Biographic Sketch: Powell’s Pearls: Hans Peter Hinselmann, MD (1884-1959). Obstet Gynecol Surv. 2004 Oct;59(10):693–5.
dc.relation.referencesFusco E, Padula F, Mancini E, Cavaliere A, Grubisic G. History of colposcopy: a brief biography of Hinselmann. J Prenat Med. 2008 Apr;2(2):19–23
dc.relation.referencesde Costa C. ‘ Ab umbris ad lumina vitae ’ a short history of colposcopy. Cancer. 2012;14(1):52–53.
dc.relation.referencesCho S, Groves E, Lao V. History of High-Resolution Anoscopy. Clin Colon Rectal Surg. 2018 Nov 2;31(06):336–46.
dc.relation.referencesOʼConnor JJ. The study of anorectal disease by colposcopy. Dis Colon Rectum. 1977 Oct;20(7):570–2.
dc.relation.referencesO’Connor JJ. Colposcopy in anorectal disease. South Med J. 1979;(12):1559–1560.
dc.relation.referencesJay N. High-resolution anoscopy: Procedure and findings. Semin Colon Rectal Surg. 2017 Jun;28(2):75–80.
dc.relation.referencesBasu P, Sankaranarayanan R. Atlas of Colposcopy – Principles and Practice: IARC CancerBase No. 13 [Internet]. Lyon, France: International Agency for Research on Cancer; 2017. Available from: https://screening.iarc.fr/atlascolpo.php
dc.relation.referencesKühn W. Kolposkopie zur Früherkennung des Zervixkarzinoms. Pathologe. 2011 Nov 9;32(6):497–504.
dc.relation.referencesO’Connor DM. A Tissue Basis for Colposcopic Findings. Obstet Gynecol Clin North Am [Internet]. 2008;35(4):565–82. Available from: http://dx.doi.org/10.1016/j.ogc.2008.09.009
dc.relation.referencesKhan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki A-B, et al. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. J Low Genit Tract Dis. 2017 Oct;21(4):223–9.
dc.relation.referencesHammes LS, Naud P, Passos EP, Matos J, Brouwers K, Rivoire W, et al. Value of the International Federation for Cervical Pathology and Colposcopy (IFCPC) Terminology in Predicting Cervical Disease. J Low Genit Tract Dis. 2007 Jul;11(3):158–65.
dc.relation.referencesVercellino GF, Erdemoglu E, Chiantera V, Vasiljeva K, Drechsler I, Cichon G, et al. Validity of the Colposcopic Criteria Inner Border Sign, Ridge Sign, and Rag Sign for Detection of High-Grade Cervical Intraepithelial Neoplasia. Obstet Gynecol. 2013 Mar;121(3):624–31.
dc.relation.referencesUnderwood M, Arbyn M, Parry-Smith W, De Bellis-Ayres S, Todd R, Redman C, et al. Accuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2012 Oct;119(11):1293–301.
dc.relation.referencesWentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, et al. Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy. J Clin Oncol. 2015 Jan 1;33(1):83–9.
dc.relation.referencesWaxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, et al. ASCCP Colposcopy Standards: How do we perform colposcopy? Implications for establishing standards. J Low Genit Tract Dis. 2017 Oct;21(4):235–41.
dc.relation.referencesBornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, et al. 2011 Colposcopic Terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012 Jul;120(1):166–72.
dc.relation.referencesBornstein J, Sideri M, Tatti S, Walker P, Prendiville W, Haefner HK. 2011 Terminology of the Vulva of the International Federation for Cervical Pathology and Colposcopy. J Low Genit Tract Dis. 2012 Jul;16(3):290–5.
dc.relation.referencesGagné HM. Colposcopy of the Vagina and Vulva. Obstet Gynecol Clin North Am. 2008 Dec;35(4):659–69.
dc.relation.referencesCamus M, Lesage A-C, Fléjou J-F, Hoyeau N, Atienza P, Etienney I. Which Lesions Should Be Biopsied During High-Resolution Anoscopy? Prospective Descriptive Study of Simple Morphological Criteria. J Low Genit Tract Dis. 2015 Apr;19(2):156–60.
dc.relation.referencesChan JK, Monk BJ, Brewer C, Keefe KA, Osann K, McMeekin S, et al. HPV infection and number of lifetime sexual partners are strong predictors for “natural” regression of CIN 2 and 3. Br J Cancer. 2003;89(6).
dc.relation.referencesSolomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. J Am Med Assoc. 2002;
dc.relation.referencesDarragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: Background and consensus recommendations from the college of American pathologists and the American society for colposcopy and cervical pathology. Int J Gynecol Pathol. 2013;
dc.relation.referencesPerkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis [Internet]. 2020 Apr 1 [cited 2020 Nov 15];24(2):102–31. Available from: http://journals.lww.com/10.1097/LGT.0000000000000525
dc.relation.referencesde Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection. Vol. 47, Best Practice and Research: Clinical Obstetrics and Gynaecology. Bailliere Tindall Ltd; 2018. p. 2–13.
dc.relation.referencesMelnikow J, Nuovo J, Willan AR, Chan BKS, Howell LP. Natural history of cervical squamous intraepithelial lesions: A meta- analysis [Internet]. Vol. 92, Obstetrics and Gynecology. Elsevier Inc.; 1998 [cited 2020 Nov 19]. p. 727–35. Available from: https://ucdavis.pure.elsevier.com/en/publications/natural-history-of-cervical-squamous-intraepithelial-lesions-a-me
dc.relation.referencesKi EY, Park JS. Natural History of Human Papillomavirus Infection. Curr Obstet Gynecol Rep [Internet]. 2014 Jun 23 [cited 2020 Nov 19];3(2):123–7. Available from: https://link.springer.com/article/10.1007/s13669-014-0082-y
dc.relation.referencesBekos C, Schwameis R, Heinze G, Gärner M, Grimm C, Joura E, et al. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: Results from large cohort, systematic review, meta-analysis. Vol. 8, Scientific Reports. 2018.
dc.relation.referencesCOPPOLILLO EF, DE RUDA VEGA HM, BRIZUELA J, ELISETH MC, BARATA A, PERAZZI BE. High-grade cervical neoplasia during pregnancy: diagnosis, management and postpartum findings. Acta Obstet Gynecol Scand [Internet]. 2013 Mar 1 [cited 2020 Nov 19];92(3):293–7. Available from: http://doi.wiley.com/10.1111/j.1600-0412.2012.01521.x
dc.relation.referencesTainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: Systematic review and meta-analysis [Internet]. Vol. 360, BMJ (Online). BMJ Publishing Group; 2018 [cited 2020 Nov 26]. p. 499. Available from: http://dx.doi.org/10.1136/bmj.k499
dc.relation.referencesZhang S-K, Kang L-N, Chang IJ, Zhao F-H, Hu S-Y, Chen W, et al. The Natural History of Cervical Cancer in Chinese Women: Results from an 11-Year Follow-Up Study in China Using a Multistate Model. 2014 [cited 2020 Nov 26]; Available from: http://cebp.aacrjournals.org/
dc.relation.referencesJones H, Rock J. Te Linde. Ginecología quirúrgica, Undécima Edición [Internet]. 11th ed. Jones H, Rock J, editors. Wolters Kluwer. Barcelona, España: Wolters Kluwer; 2017 [cited 2020 Nov 26]. Available from: https://solution.lww.com/Book/Show/686902
dc.relation.referencesEgemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, et al. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. J Low Genit Tract Dis. 2020;24(2).
dc.relation.referencesMartin-Hirsch PPL, Paraskevaidis E, Bryant A, Dickinson HO. Surgery for cervical intraepithelial neoplasia. Vol. 2013, Cochrane Database of Systematic Reviews. 2013.
dc.relation.referencesKyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: Systematic review and meta-analysis. Vol. 354, BMJ (Online). 2016.
dc.relation.referencesElit L, Levine MN, Julian JA, Sellors JW, Lytwyn A, Chong S, et al. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia. Cancer [Internet]. 2011 Apr 1 [cited 2020 Nov 26];117(7):1438–45. Available from: http://doi.wiley.com/10.1002/cncr.25635
dc.relation.referencesFouw M, Oosting RM, Rutgrink A, Dekkers OM, Peters AAW, Beltman JJ. A systematic review and meta‐analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low‐ and middle‐income countries. Int J Gynecol Obstet [Internet]. 2019 Oct 22 [cited 2020 Nov 26];147(1):4–18. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.12904
dc.relation.referencesMoscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010;116(6).
dc.relation.referencesMutombo AB, Simoens C, Tozin R, Bogers J, Van Geertruyden JP, Jacquemyn Y. Efficacy of commercially available biological agents for the topical treatment of cervical intraepithelial neoplasia: A systematic review. Syst Rev [Internet]. 2019 Jun 7 [cited 2020 Nov 19];8(1):132. Available from: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1050-4
dc.relation.referencesJiang Y, Chen C, Li L. Comparison of cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ (ACIS): A systematic review and meta-analysis. Vol. 12, PLoS ONE. 2017.
dc.relation.referencesFeng Y, Zhang Z, Lou T, Wang S, Bai H, Zhang Z. The safety of fertility preservation for microinvasive cervical adenocarcinoma: a meta-analysis and trial sequential analysis [Internet]. Vol. 298, Archives of Gynecology and Obstetrics. Springer Verlag; 2018 [cited 2020 Nov 26]. p. 465–75. Available from: https://link.springer.com/article/10.1007/s00404-018-4799-0
dc.relation.referencesSalani R, Puri I, Bristow RE. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am J Obstet Gynecol. 2009 Feb 1;200(2):182.e1-182.e5.
dc.relation.referencesPreti M, Scurry J, Marchitelli CE, Micheletti L. Vulvar intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1051–62
dc.relation.referencesCare GP. Acog c ommittee opinion. Obstet Gynecol. 2017;130(4):e210
dc.relation.referencesSerrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47(2018):14–26.
dc.relation.referencesFaber MT, Sand FL, Albieri V, Norrild B, Kjær SK, Verdoodt F. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer. 2017;141(6):1161–9.
dc.relation.referencesPreti M, Rotondo JC, Holzinger D, Micheletti L, Gallio N, McKay-Chopin S, et al. Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infect Agent Cancer. 2020;15(1):4–11
dc.relation.referencesMadsen BS, Jensen HL, Van Den Brule AJC, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina - Population-based case-control study in Denmark. Int J Cancer. 2008;122(12):2827–34.
dc.relation.referencesSatmary W, Holschneider CH, Brunette LL, Natarajan S. Vulvar intraepithelial neoplasia: Risk factors for recurrence. Gynecol Oncol. 2018;148(1):126–31.
dc.relation.referencesBleeker MCG, Visser PJ, Overbeek LIH, Van Beurden M, Berkhof J. Lichen sclerosus: Incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25(8):1224–30.
dc.relation.referencesGalindo Díaz LF. PREVALENCIA DE ENFERMEDADES DE VULVA SEGÚN GRUPOS ETÁREOS EN PACIENTES ESTUDIADAS CON BIOPSIA DE PIEL EN UNA INSTITUCIÓN DE TERCER NIVEL ENTRE LOS AÑOS 2009 A 2013. Universidad Nacional de Colombia.; 2014.
dc.relation.referencesMathews CA, Walker JL. 2 - Lesiones preinfiltrantes de la vagina y la vulva, y procesos relacionados. Nineth Edi. Oncología ginecológica clínica + acceso web. 2018. 20–37 p.
dc.relation.referencesYang EJ. Human Papilloma Virus–Associated SquamousNeoplasia of the LowerAnogenital Tract. Surg Pathol Clin. 2019;12:263–79.
dc.relation.referencesLebreton M, Carton I, Brousse S, Lavoué V, Body G, Levêque J, et al. Vulvar intraepithelial neoplasia: Classification, epidemiology, diagnosis, and management. J Gynecol Obstet Hum Reprod. 2020;
dc.relation.referencesBornstein J, Bogliatto F, Haefner HK, Stockdale CK, Preti M, Bohl TG, et al. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions. Obstet Gynecol. 2016;127(2):264–8.
dc.relation.referencesDel Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Vol. 62, Histopathology. 2013. p. 161–75.
dc.relation.referencesNitecki R, Feltmate CM. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review. Curr Probl Cancer. 2018;42(5):476–85.
dc.relation.referencesAndía, D., Bosch, J.M., Cararach, M., Coronado, P., de Sanjosé, S., López, J.A., Martínez J.C., Puig-Tintoré, L.M., Vidart J. AEPCC-Guía: Neoplasia vulvar intraepitelial (VIN). 2015;39.
dc.relation.referencesFouéré S, Biver-Dalle C, Prétet J-L, Mougin C, Aubin F. Lesiones cutáneas y mucosas asociadas al virus del papiloma humano. EMC - Dermatología. 2016;50(1):1–12.
dc.relation.referencesJones RW, Rowan DM. Spontaneous regression of vulvar intraepithelial neoplasia 2-3. Obstet Gynecol. 2000;96(3):470–2.
dc.relation.referencesFonseca-Moutinho JA. Neoplasia intraepitelial vulvar: Um problema atual. Rev Bras Ginecol e Obstet. 2008;30(8):420–6.
dc.relation.referencesRichter ON, Petrow W, Wardelmann E, Dorn C, Kupka M, Ulrich U. Bowenoid papulosis of the vulva - Immunotherapeutical approach with topical imiquimod. Arch Gynecol Obstet. 2003;268(4):333–6.
dc.relation.referencesCrum CP, Fu YS, Levine RU, Richart RM, Townsend DE, Fenoglio CM. Intraepithelial squamous lesions of the vulva: Biologic and histologic criteria for the distinction of condylomas from vulvar intraepithelial neoplasia. Am J Obstet Gynecol. 1982;144(1):77–83.
dc.relation.referencesBigby SM, Eva LJ, Fong KL, Jones RW. The natural history of vulvar intraepithelial neoplasia, differentiated type: Evidence for progression and diagnostic challenges. Int J Gynecol Pathol. 2016;35(6):574–84
dc.relation.referencesConsuegra-Mayor CP, Molina-Campo D, Egea-Bermejo E, Garavito de Egea G. El virus del papiloma humano (HPV), agente viral importante precusor de la mayoría de las displasias o cáncer cervical. Salud Uninorte. 2004;2004(19):3–13.
dc.relation.referencesRevercez P, De Rider M, Nazac A. Patología maligna vulvar en la mujer adulta. EMC - Ginecol. 2018;54(2):1–9.
dc.relation.referencesAllbritton JI. Vulvar Neoplasms, Benign and Malignant. Obstet Gynecol Clin North Am. 2017;44(3):339–52.
dc.relation.referencesYang EJ, Kong CS, Longacre TA. Vulvar and Anal Intraepithelial Neoplasia: Terminology, Diagnosis, and Ancillary Studies. Adv Anat Pathol. 2017;24(3):136–50.
dc.relation.referencesDe Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450–61
dc.relation.referencesDylan Trotsek. 済無No Title No Title. J Chem Inf Model. 2017;110(9):1689–99.
dc.relation.referencesJaneiro RIODE, Pereyra EG. Neoplasia intraepitelial vulvar. Arch Médicos Actual en Tracto Genit Infer. 2013;15–24.
dc.relation.referencesCohen PA, Anderson L, Eva L, Scurry J. Clinical and molecular classification of vulvar squamous pre-cancers. Int J Gynecol Cancer. 2019;29(4):821–8.
dc.relation.referencesBogliatto F. Vulvar Intraepithelial Neoplasia. In: VUlvar Disease. 1st ed. Turin Italy; 2019. p. 371–8.
dc.relation.referencesBansal J, Datta S. Pruritus vulvae. Obstet Gynaecol Reprod Med. 2019;29(6):170–4.
dc.relation.referencesTristram A, Hurt CN, Madden T, Powell N, Man S, Hibbitts S, et al. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): A multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2014;15(12):1361–8.
dc.relation.referencesTerlou A, Van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial. Gynecol Oncol. 2011;121(1):157–62.
dc.relation.referencesDe Witte CJ, Van De Sande AJM, Van Beekhuizen HJ, Koeneman MM, Kruse AJ, Gerestein CG. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: A review. Gynecol Oncol. 2015;139(2):377–84.
dc.relation.referencesHelm CW. Is cidofovir a better treatment than imiquimod for high-grade vulval intraepithelial neoplasia? BJOG An Int J Obstet Gynaecol. 2018;125(9):1178.
dc.relation.referencesNordin A, Lawrie TA, Kaushik S, Pepas L, Bryant A. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia. Cochrane Database Syst Rev. 2015;2015(8).
dc.relation.referencesMahner S, Wölber L. Surgery or topical therapy for vulval intraepithelial neoplasia. Lancet Oncol. 2014;15(12):1287–8.
dc.relation.referencesFrancis JA, Eiriksson L, Dean E, Sebastianelli A, Bahoric B, Salvador S. No. 370-Management of Squamous Cell Cancer of the Vulva. J Obstet Gynaecol Canada. 2019;41(1):89–101.
dc.relation.referencesCommittee Opinion No. 675 Summary: Management of Vulvar Intraepithelial Neoplasia. Obs Gynecol. 2016;128(4):937–8.
dc.relation.referencesWeyers W. The centennial of Bowen’s disease—a critical review on the occasion of the100th anniversary of its original description. Dermatol Pract Concept [Internet]. 2012 [cited 2020 Nov 30];2(4
dc.relation.referencesORIEL JD, WHIMSTER IW. CARCINOMA IN SITU ASSOCIATED WITH VIRUS‐CONTAINING ANAL WARTS. Br J Dermatol [Internet]. 1971 [cited 2020 Nov 30];84(1):71–3.
dc.relation.referencesFenger C, Nielsen VT. DYSPLASTIC CHANGES IN THE ANAL CANAL EPITHELIUM IN MINOR SURGICAL SPECIMENS. Acta Pathol Microbiol Scand Sect A Pathol [Internet]. 1981 [cited 2020 Nov 30];89 A(1–6):463–5.
dc.relation.referencesNayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytol [Internet]. 2015 Jun 15 [cited 2020 Nov 28];59(2):121–32.
dc.relation.referencesDandapani S V, Eaton M, Thomas CR, Pagnini PG. HIV- positive anal cancer: an update for the clinician. J Gastrointest Oncol [Internet]. 2010 [cited 2020 Nov 30];1(1):34–44.
dc.relation.referencesShiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr [Internet]. 2009 Dec [cited 2020 Nov 30];52(5):611–22.
dc.relation.referencesPapatla K, Halpern MT, Hernandez E, Brown J, Benrubi D, Houck K, et al. Second primary anal and oropharyngeal cancers in cervical cancer survivors. In: American Journal of Obstetrics and Gynecology. Mosby Inc.; 2019. p. 478.e1-478.e6
dc.relation.referencesDe Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vézina S, Coté P, et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis [Internet]. 2011 May 1 [cited 2020 Nov 30];52(9):1174–81.
dc.relation.referencesNelson RA, Lai LL. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Cancer [Internet]. 2017 Oct 15 [cited 2020 Nov 30];123(20):4013–21.
dc.relation.referencesYang EJ, Quick MC, Hanamornroongruang S, Lai K, Doyle LA, McKeon FD, et al. Microanatomy of the cervical and anorectal squamocolumnar junctions: A proposed model for anatomical differences in HPV-related cancer risk. Mod Pathol [Internet]. 2015 Jul 2 [cited 2020 Nov 30];28(7):994–1000.
dc.relation.referencesKost BP, Hofmann J, Stoellnberger S, Bergauer F, Blankenstein T, Alba-Alejandre I, et al. Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populations. Oncol Lett [Internet]. 2017 Apr 1 [cited 2020 Nov 30];13(4):2495–501.
dc.relation.referencesDonadio MDS, Riechelmann RP. Anal canal cancer in Brazil: Why should we pay more attention to the epidemiology of this rare disease? [Internet]. Vol. 14, ecancermedicalscience. ecancer Global Foundation; 2020 [cited 2020 Nov 30].
dc.relation.referencesAlemany L, Saunier M, Alvarado-Cabrero I, Quirõs B, Salmeron J, Shin HR, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer [Internet]. 2015 Jan 1 [cited 2020 Nov 30];136(1):98–107.
dc.relation.referencesLyons KM, Butler SL. Anal intraepithelial neoplasia from a pathologists point of view. Clin Colon Rectal Surg [Internet]. 2018 [cited 2020 Nov 30];31(6):328–35.
dc.relation.referencesWalts AE, Lechago J, Bose S. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol [Internet]. 2006 Jul [cited 2020 Nov 30];30(7):795–801.
dc.relation.referencesAlbuquerque A, Rios E, Schmitt F. Recommendations favoring anal cytology as a method for anal cancer screening: A systematic review [Internet]. Vol. 11, Cancers. MDPI AG; 2019 [cited 2020 Nov 30]
dc.relation.referencesCarter TJ, Jeyaneethi J, Kumar J, Karteris E, Glynne-Jones R, Hall M. Identification of cancer-associated circulating cells in anal cancer patients. Cancers (Basel) [Internet]. 2020 Aug 1 [cited 2020 Nov 30];12(8):1–12.
dc.relation.referencesNyitray AG, D’Souza G, Stier EA, Clifford G, Chiao EY. The Utility of Digital Anal Rectal Examinations in a Public Health Screening Program for Anal Cancer. J Low Genit Tract Dis [Internet]. 2020 Apr 1 [cited 2020 Nov 30];24(2):192–6.
dc.relation.referencesHerfs M, Longuespée R, Quick CM, Roncarati P, Suarez-Carmona M, Hubert P, et al. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. J Pathol [Internet]. 2017 Mar 1 [cited 2020 Nov 30];241(4):522–33.
dc.relation.referencesLondon S, Hoilat GJ, Tichauer MB. Anoscopy [Internet]. StatPearls. StatPearls Publishing; 2020 [cited 2020 Nov 30].
dc.relation.referencesPineda CE, Berry JM, Welton ML. High resolution anoscopy and targeted treatment of high-grade squamous intraepithelial lesions. Dis Colon Rectum [Internet]. 2006 Jan [cited 2020 Nov 30];49(1):126.
dc.relation.referencesLong KC, Menon R, Bastawrous A, Billingham R. Screening, Surveillance, and Treatment of Anal Intraepithelial Neoplasia [Internet]. Vol. 29, Clinics in Colon and Rectal Surgery. Thieme Medical Publishers, Inc.; 2016 [cited 2020 Nov 30]. p. 57–64
dc.relation.referencesJay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: Relationship to histopathology. Dis Colon Rectum [Internet]. 1997 Aug [cited 2020 Nov 30];40(8):919–28.
dc.relation.referencesGomes A, Minata MK, Jukemura J, de Moura EGH. Video anoscopy: results of routine anal examination during colonoscopies. Endosc Int Open [Internet]. 2019 Nov [cited 2020 Nov 30];07(11):E1549–62.
dc.relation.referencesSehnal B, Dusek L, Cibula D, Zima T, Halaska M, Driak D, et al. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. J Clin Virol [Internet]. 2014 Jan [cited 2020 Nov 30];59(1):18–23.
dc.relation.referencesNasioutziki M, Chatzistamatiou K, Loufopoulos PD, Vavoulidis E, Tsampazis N, Pratilas GC, et al. Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy. Infect Agent Cancer [Internet]. 2020 Apr 15 [cited 2020 Nov 30];15(1).
dc.relation.referencesRobison K, Cronin B, Bregar A, Luis C, Disilvestro P, Schechter S, et al. Anal cytology and human papillomavirus genotyping in women with a history of lower genital tract neoplasia compared with low-risk women. Obstet Gynecol [Internet]. 2015 Dec 1 [cited 2020 Nov 30];126(6):1294–300
dc.relation.referencesEhrenpreis ED, Smith DG. Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model. Papillomavirus Res [Internet]. 2018 Jun 1 [cited 2020 Nov 30];5:38–45.
dc.relation.referencesUrbute A, Rasmussen CL, Belmonte F, Obermueller T, Prigge ES, Arbyn M, et al. Prognostic significance of HPV DNA and p16INK4a in anal cancer: A systematic review and meta-analysis [Internet]. Vol. 29, Cancer Epidemiology Biomarkers and Prevention. American Association for Cancer Research Inc.; 2020 [cited 2020 Nov 30]. p. 703–10.
dc.relation.referencesMistrangelo M, Salzano A. Progression of LSIL to HSIL or SCC: is anoscopy and biopsy good enough? [Internet]. Vol. 23, Techniques in Coloproctology. Springer-Verlag Italia s.r.l.; 2019 [cited 2020 Nov 30]. p. 303–4
dc.relation.referencesSteele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD. Practice parameters for anal squamous neoplasms. Dis Colon Rectum [Internet]. 2012 Jul [cited 2020 Nov 30];55(7):735–49.
dc.relation.referencesPalefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia. N Engl J Med [Internet]. 2011 Oct 27 [cited 2020 Nov 30];365(17):1576–85.
dc.relation.referencesStankiewicz Karita HC, Hauge K, Magaret A, Mao C, Schouten J, Grieco V, et al. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol. JAMA Netw open [Internet]. 2019 Apr 5 [cited 2020 Nov 30];2(4):e190819. /
dc.relation.referencesGibson SJ, Lindh JM, Riter TR, Gleason RM, Rogers LM, Fuller AE, et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol [Internet]. 2002 [cited 2020 Nov 30];218(1–2):74–86.
dc.relation.referencesMahto M, Nathan M, O’Mahony C. More than a decade on: Review of the use of imiquimod in lower anogenital intraepithelial neoplasia [Internet]. Vol. 21, International Journal of STD and AIDS. Int J STD AIDS; 2010 [cited 2020 Nov 30]. p. 8–16.
dc.relation.referencesMaehara Y, Oki E, Saeki H, Tokunaga E, Kitao H, Iimori M, et al. Evolving 5-fluorouracil therapy to achieve enhanced efficacy-past and current efforts of researchers [Internet]. Vol. 43, Japanese Journal of Cancer and Chemotherapy. Japanese Journal of Cancer and Chemotherapy Publishers Inc.; 2016 [cited 2020 Nov 30]. p. 845–54
dc.relation.referencesRichel O, Wieland U, De Vries HJC, Brockmeyer NH, Van Noesel C, Potthoff A, et al. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol [Internet]. 2010 Dec [cited 2020 Nov 30];163(6):1301–7.
dc.relation.referencesCoremans G, Snoeck R. Cidofovir: Clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions [Internet]. Vol. 10, Expert Opinion on Pharmacotherapy. Expert Opin Pharmacother; 2009 [cited 2020 Nov 30]. p. 1343–52.
dc.relation.referencesSendagorta E, Bernardino JI, Álvarez-Gallego M, Feíto M, Feltes R, Beato MJ, et al. Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: A pilot clinical trial. AIDS [Internet]. 2016 Jan 2 [cited 2020 Nov 30];30(1):75–82. /
dc.relation.referencesVan Der Snoek EM, Den Hollander JC, Aans JB, Sterenborg HJCM, Van Der Ende ME, Robinson DJ. Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3. Lasers Surg Med [Internet]. 2012 Oct [cited 2020 Nov 30];44(8):637–44.
dc.relation.referencesNathan M, Hickey N, Mayuranathan L, Vowler SL, Singh N. Treatment of anal human papillomavirus-associated disease: A long term outcome study. Int J STD AIDS [Internet]. 2008 Jul [cited 2020 Nov 30];19(7):445–9.
dc.relation.referencesCranston RD, Baker JR, Liu Y, Wang L, Elishaev E, Ho KS. Topical application of trichloroacetic acid is efficacious for the treatment of internal anal high-grade squamous intraepithelial lesions in HIV-positive men. Sex Transm Dis [Internet]. 2014 [cited 2020 Nov 30];41(7):420–6.
dc.relation.referencesMarks DK, Goldstone SE. Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men. J Acquir Immune Defic Syndr [Internet]. 2012 Mar 1 [cited 2020 Nov 30];59(3):259–65.
dc.relation.referencesBurgos J, Curran A, Landolfi S, Navarro J, Tallada N, Guelar A, et al. The effectiveness of electrocautery ablation for the treatment of high-grade anal intraepithelial neoplasia in HIV-infected men who have sex with men. HIV Med [Internet]. 2016 Aug 1 [cited 2020 Nov 30];17(7):524–31. /
dc.relation.referencesWatemberg S, Landau O, Avrahami R, Kaplan I, Giler S, Kott I. Successful treatment of anal tumors with CO2 laser in elderly, high-risk patients. J Clin Laser Med Surg [Internet]. 1996 [cited 2020 Nov 30];14(3):115–7.
dc.relation.referencesBinda GA, Gagliardi G, Dal Conte I, Verra M, Cassoni P, Cavazzoni E, et al. Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR). Tech Coloproctol [Internet]. 2019 Jun 1 [cited 2020 Nov 30];23(6):513–28.
dc.relation.referencesWillems N, Libois A, Nkuize M, Feoli F, Delforge M, DeWit S. Treatment of anal dysplasia in HIV-positive men who have sex with men in a large AIDS reference centre. Acta Clin Belgica Int J Clin Lab Med [Internet]. 2017 Jan 2 [cited 2020 Nov 30];72(1):29–35.
dc.relation.referencesBrown SR, Skinner P, Tidy J, Smith JH, Sharp F, Hosie KB. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen’s disease). Br J Surg [Internet]. 1999 Aug 1 [cited 2020 Nov 30];86(8):1063–6.
dc.relation.referencesPalefsky JM. Screening to prevent anal cancer: Current thinking and future directions [Internet]. Vol. 123, Cancer Cytopathology. John Wiley and Sons Inc.; 2015 [cited 2020 Nov 30]. p. 509–10.
dc.relation.referencesClarke MA, Wentzensen N. Strategies for Screening and Early Detection of Anal Cancers: A Narrative and Systematic Review and Meta-Analysis of Cytology, HPV Testing, and Other Biomarkers [Internet]. Vol. 126, Cancer Cytopathology. John Wiley and Sons Inc.; 2018 [cited 2020 Nov 30]. p. 447–60.
dc.relation.referencesOrganización Panamericana de la Salud. Experiencias con la implementación de programas de tamizaje de cáncer cervicouterino basados en la prueba de VPH. Informe de reunión. 2018;1–34.
dc.relation.referencesGutiérrez RQ. CÁNCER OROFARÍNGEO Y VIRUS DEL PAPILOMA HUMANO EN CABEZA Y CUELLO : RELACIONES FISIOPATOLÓGICAS Y EPIDEMIOLÓGICAS. Rev Costarric Salud Pública. 2018;27(1):16–23.
dc.relation.referencesFouéré S, Biver-Dalle C, Prétet J-L, Mougin C, Aubin F. Lesiones cutáneas y mucosas asociadas al virus del papiloma humano. EMC - Dermatología. 2016;50(1):1–12.
dc.relation.referencesSerrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47(2018):14–26.
dc.relation.referencesFaber MT, Sand FL, Albieri V, Norrild B, Kjær SK, Verdoodt F. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer. 2017;141(6):1161–9.
dc.relation.referencesMazzadi A, Paolino M, Arrossi S. Aceptabilidad y conocimientos sobre la vacunación contra el virus del papiloma humano (VPH) en médicos ginecólogos de la Argentina. Salud Publica Mex. 2012;54(5):515–22.
dc.relation.referencesPosada DH, Stella L, Acevedo T, Arredondo MV. Infección por el virus del papiloma humano de alto riesgo y factores asociados en canal anal de pacientes con VIH en Medellín , 2017 – 2018. 2020;1–11.
dc.relation.referencesPimple S, Mishra G, Shastri S. Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol. 2016;28(1):4–10.
dc.relation.referencesGaitán-Duarte H. Las infecciones de transmisión sexual: un problema de salud pública que Colombia debe enfrentar. Rev Colomb Obstet Ginecol. 2017;68(3):164.
dc.relation.referencesMoya-Salazar JJ, Rojas-Zumaran VA. Tendencias en la investigación del virus de papiloma humano en Latinoamérica Frente a los países de altos ingresos. Rev Colomb Obstet Ginecol. 2017;68(3):202–17.
dc.relation.referencesHerrera MPJ. CÁNCER DE MAMA Y CUELLO UTERINO. Bogotá; 2018.
dc.relation.referencesWorld Health Organization W. Draft: Global Strategy towards eliminating cervical cancer as a public health problem. WHO Press. 2020;(April):1–35.
dc.relation.referencesCanfell K. Towards the global elimination of cervical cancer. Papillomavirus Res. 2019;8(June):100170
dc.relation.referencesMerle J, Gates M. Análisis de la situación del cáncer cervicouterino en América Latina y el Caribe. Washington, D.C; 2004.
dc.relation.referencesPerkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102–31.
dc.relation.referencesCarcopino X. Citología cervical y conducta práctica en caso de frotis anormal. EMC - Ginecol. 2019;55(1):1–11.
dc.relation.referencesSolé-Sedeno JM, Mancebo G, Miralpeix E, Lloveras B, Bellosillo B, Alameda F, et al. Utility of Human Papillomavirus Genotyping in the Management of Low-Grade Squamous Intraepithelial Lesions. J Low Genit Tract Dis. 2018;22(1):13–6.
dc.relation.referencesLazcano-Ponce EC, Aguilar PN, Alonso de Ruiz P et al: Programa de detección Oportuna de Cáncer Cervical en México. Cancerologia. 1996;42(3):123–40.
dc.relation.referencesFerreccio C. Nuevas estrategias de prevención y control de cáncer de cuello uterino en Chile. Salud Publica Mex. 2018;60(6, nov-dic):713.
dc.relation.referencesHirth J. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccines Immunother. 2019;15(1):146–55.
dc.relation.referencesKM S, KL K, MR S, GM M, AD P, ER U, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002;186(10):1396–402.
dc.relation.referencesDiane M Harper HP study group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.
dc.relation.referencesMarkowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137(3)
dc.relation.referencesConsuegra-Mayor CP, Molina-Campo D, Egea-Bermejo E, Garavito de Egea G. El virus del papiloma humano (HPV), agente viral importante precusor de la mayoría de las displasias o cáncer cervical. Salud Uninorte. 2004;2004(19):3–13.
dc.relation.referencesDe Witte CJ, Van De Sande AJM, Van Beekhuizen HJ, Koeneman MM, Kruse AJ, Gerestein CG. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: A review. Gynecol Oncol. 2015;139(2):377–84.
dc.relation.referencesWoodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: Unresolved issues. Nat Rev Cancer. 2007;7(1):11–22.
dc.relation.referencesPan American Health Organization. Integrating HPV Testing in Cervical Cancer Screening Programs. 2016. 68 p.
dc.relation.referencesSalud OP de la. PLAN DE ACCIÓN SOBRE LA PREVENCIÓN Y EL CONTROL DEL CÁNCER CERVICOUTERINO 2018-2030. In Washington D.C.; 2018. p. 48.
dc.relation.referencesNitecki R, Feltmate CM. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review. Curr Probl Cancer. 2018;42(5):476–85.
dc.relation.referencesBoguñá N, Capdevila L, Jané-Salas E. Relationship of human papillomavirus with diseases of the oral cavity. Med Clínica (English Ed. 2019;153(4):157–64.
dc.relation.referencesCastellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016;108(6):1–12.
dc.relation.referencesStates M, Strategic WHO, Group A, Grade T, Membres E. Weekly epidemiological record Relevé épidémiologique hebdomadaire. 2014;(43):465–92.
dc.relation.referencesLeón-Maldonado L, Wentzell E, Brown B, Allen-Leigh B, Torres-Ibarra L, Salmerón J, et al. Perceptions and experiences of human papillomavirus (HPV) infection and testing among low-income Mexican women. PLoS One. 2016;11(5):1–14.
dc.relation.referencesCanfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591–603.
dc.relation.referencesRobles C, Hernández M de la L, Almonte M. Alternative HPV vaccination schedules in Latin America. Salud Publica Mex. 2018;60(6):693–702.
dc.relation.referencesSt. Laurent J, Luckett R, Feldman S. HPV vaccination and the effects on rates of HPV-related cancers. Curr Probl Cancer. 2018;42(5):493–506.
dc.relation.referencesPaavonen J et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301–14.
dc.relation.referencesAmaro-Filho SM, Pereira Chaves CB, Felix SP, Basto DL, de Almeida LM, Moreira MAM. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer. Papillomavirus Res. 2018;5(February):172–9.
dc.relation.referencesPeña N, Carrillo D, Muñoz JP, Chnaiderman J, Urzúa U, León O, et al. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. PLoS One. 2015;10(4):1–16.
dc.relation.referencesGrandahl M, Paek SC, Grisurapong S, Sherer P, Tydén T, Lundberg P. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PLoS One. 2018;13(2):1–17.
dc.relation.referencesBaltar-Moreno A. Moreno-Castro C, editor. Campañas institucionales en salud pública. El caso contra el virus VPH. Madrid: Dextra Editorial; 2017. Rev Gerenc y Polit Salud. 2019;18(37):1–4.
dc.relation.referencesTiempo E, Se N, Carmen E, Ampliado P, Mundo T. L a vacunación contra el virus del papiloma humano en Colombia. Rev Gerenc y Polit Salud. 2014;13(27):5–9.
dc.relation.referencesMartínez M, Estévez A, Quijada H, Walteros D, Tolosa N, Paredes A, et al. Brote de evento de etiología desconocida en el municipio de El Carmen de Bolívar, Bolívar, 2014. Inf Quinc epidemiológico Nac. 2015;20(3–4):42–77
dc.relation.referencesWiesner C, Piñeros M, Trujillo LM, Cortés C, Ardila J. Aceptabilidad de la vacuna contra el virus papiloma humano en padres de adolescentes, en Colombia. Rev Salud Publica. 2010;12(6):961–73.
dc.relation.referencesMcCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: A qualitative study. Sex Transm Infect. 2006;82(2):169–74.
dc.relation.referencesCarolina Wiesnera, b,*, Lina Rincóna ÓG, Piñerosd M, Gonzáleze M, Natascha Ortizf, Gustavo Hernándezg MM, Robles y R. Barreras para la implementación de la prueba ADN-VPH como técnica de tamización primaria para cáncer de cuello uterino en un área demostrativa en Colombia. Rev Colomb Cancerol. 2013;17(3):93–102.
dc.relation.referencesCohen PA, Anderson L, Eva L, Scurry J. Clinical and molecular classification of vulvar squamous pre-cancers. Int J Gynecol Cancer. 2019;29(4):821–8.
dc.relation.referencesLehtinen M, Baussano I, Paavonen J, Vänskä S, Dillner J. Eradication of human papillomavirus and elimination of HPV-related diseases–scientific basis for global public health policies. Expert Rev Vaccines. 2019;18(2):153–60.
dc.relation.referencesHirth JM, Rahman M, Smithc JS, Berenson AB. Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010. Hum Vaccines Immunother. 2014;10(12):3475–83.
dc.relation.referencesManhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, et al. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis. 2006;33(8):502–8.
dc.relation.referencesOchalek J, Abbas K, Claxton K, Jit M, Lomas J. Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries. BMJ Glob Heal. 2020;5(10):1–12.
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.proposalSquamous intraepithelial lesions of the cervix
dc.subject.proposalLesiones intraepiteliales escamosas del cuello uterino
dc.subject.proposalInfecciones por papillomavirus
dc.subject.proposalPapillomavirus infections
dc.subject.proposalVulvar neoplasms
dc.subject.proposalNeoplasias de la vulva
dc.subject.proposalAnus neoplasms
dc.subject.proposalNeoplasias del ano
dc.type.coarhttp://purl.org/coar/resource_type/c_1843
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.contentText
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2


Archivos en el documento

Thumbnail
Nombre:
1032456951.2020.pdf
Tamaño:
3.722Mb
Formato:
PDF
Descargar
Thumbnail
Nombre:
license_rdf
Tamaño:
805bytes
Formato:
application/rdf+xml
Descargar

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento

Atribución-NoComercial-SinDerivadas 4.0 InternacionalEsta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial 4.0.Este documento ha sido depositado por parte de el(los) autor(es) bajo la siguiente constancia de depósito